Sunifiram CAS:314728-85-3

Sunifiram (DM-235) is a synthetic derivative of Piracetam, although due to breaking the pyrrolidone backbone it is no longer in the Racetam class of drugs (yet by being derived from them, it is still commonly associated with this class).

Sunifiram Applications:

Sunifiram is one of the newest nootropics on the market to smart drugs family. It is considered to be in the ampakine family of supplements. It increases one’s attention span, decision making, and learning abilities. Although it is believed to work much like Piracetam, it is highly potent in comparison. The structure is similar, but some have reported Sunifiram being 1000 times more potent. In terms of its potency, it’s comparable to Noopept.

It is being researched as a memory enhancer, potentially treating Alzheimer’s patients. It provides a wide variety of benefits including; increased attention span, improved focus, and increased learning potential. It has become very popular since its release, as the benefits are high and the side-effects are low.

Sunifiram active la neurotransmission médiée par l'AMPA.

Améliorer la LTP dans une relation dose-réponse en forme de cloche.

Sunifiram aide à la libération d'acétylcholine dans le cortex cérébral.

Sunifiram augmente les niveaux d'énergie, permettant aux utilisateurs de se sentir plus motivés et d'éliminer

Augmentation du sunifirame Augmentation des niveaux de concentration, et les utilisateurs se sentent moins distraits par des stimuli externes.

Sunifiram améliore également la potentialisation à long terme, qui est la formation de nouvelles connexions concernant le stockage de la mémoire.

Sunifiram a des avantages anxiolytiques. Se sentir plus détendu est bénéfique lorsque vous essayez de vous concentrer.